Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

DFTX – definium therapeutics, inc. - common shares (US:NASDAQ)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DFTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/25
06:24 am
dftx
Definium Therapeutics (DFTX) was upgraded by Wolfe Research to "strong-buy".
Low Report
Definium Therapeutics (DFTX) was upgraded by Wolfe Research to "strong-buy".
Report
2/25
06:24 am
dftx
Definium Therapeutics (DFTX) was upgraded by Wolfe Research to "strong-buy".
Low Report
Definium Therapeutics (DFTX) was upgraded by Wolfe Research to "strong-buy".
Report
2/24
07:11 am
dftx
Rating for DFTX
Low Report
Rating for DFTX
Report
2/24
07:11 am
dftx
Rating for DFTX
Low Report
Rating for DFTX
Report
2/23
06:01 pm
dftx
Definium Therapeutics (NASDAQ:DFTX) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
Medium Report
Definium Therapeutics (NASDAQ:DFTX) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
Report
2/23
06:01 pm
dftx
Definium Therapeutics (NASDAQ:DFTX) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
Medium Report
Definium Therapeutics (NASDAQ:DFTX) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
Report
2/23
04:17 pm
dftx
Definium Therapeutics initiated with an Outperform at Wolfe Research
Low Report
Definium Therapeutics initiated with an Outperform at Wolfe Research
Report
2/23
04:17 pm
dftx
Definium Therapeutics initiated with an Outperform at Wolfe Research
Low Report
Definium Therapeutics initiated with an Outperform at Wolfe Research
Report
2/2
10:57 am
dftx
Definium Therapeutics (NASDAQ:DFTX) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Low Report
Definium Therapeutics (NASDAQ:DFTX) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Report
1/30
03:22 pm
dftx
Rating for DFTX
Low Report
Rating for DFTX
Report
1/30
03:22 pm
dftx
Rating for DFTX
Low Report
Rating for DFTX
Report
1/30
05:10 am
dftx
Definium Therapeutics initiated with a Buy at Jefferies
Low Report
Definium Therapeutics initiated with a Buy at Jefferies
Report
1/30
05:10 am
dftx
Definium Therapeutics initiated with a Buy at Jefferies
Low Report
Definium Therapeutics initiated with a Buy at Jefferies
Report
1/29
06:29 pm
dftx
Definium Therapeutics initiated with a Buy at Jefferies
Low Report
Definium Therapeutics initiated with a Buy at Jefferies
Report
1/29
06:29 pm
dftx
Definium Therapeutics initiated with a Buy at Jefferies
Low Report
Definium Therapeutics initiated with a Buy at Jefferies
Report
1/23
10:14 am
dftx
Rating for DFTX
Low Report
Rating for DFTX
Report
1/23
10:14 am
dftx
Rating for DFTX
Low Report
Rating for DFTX
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2026, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0